澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Imagion Biosystems

0.008

0.000

成交量：297.93萬

成交額：2.38萬

市值：640.81萬

市盈率：-0.73

高：0.008

開：0.008

低：0.008

收：0.008

52周最高：0.055

52周最低：0.007

股本：8.01億

流通股本：1.72億

量比：2.07

換手率：1.73%

股息：- -

股息率：- -

每股收益(TTM):-0.011

每股收益(LYR):-0.016

淨資產收益率：-2804.87%

總資產收益率：-319.68%

市淨率：-1.87

市盈率(LYR):-0.52

資料載入中...

總覽公司新聞公告

Imagion Biosystems獲FDA二期臨床試驗許可後成功融資375萬澳元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/IBX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","market":"AU","secType":"STK","nameCN":"Imagion Biosystems","latestPrice":0.008,"timestamp":1789107120000,"preClose":0.008,"halted":0,"volume":2979293,"delay":0,"changeRate":0,"nameEN":"Imagion Biosystems","floatShares":172453894,"shares":801006908,"eps":-0.010968,"marketStatus":"未開盤","change":0,"latestTime":"09-11 16:12:00 AEST","open":0.008,"high":0.008,"low":0.008,"amount":23834,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.010968,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.008,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":2.0666875786945047,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IBX.AU","preClose":0.008,"auctionPrice":0.008,"auctionVolume":5488,"auctionTime":1789341289163,"referenceTime":1789036203090,"auction":1,"marketStatus":"盘前竞价","timestamp":1789341289163}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","floatShares":172453894,"roa":"-319.68%","roe":"-2804.87%","lyrEps":-0.01553,"volumeRatio":2.0666875786945047,"shares":801006908,"dividePrice":0,"high":0.008,"amplitude":0,"preClose":0.008,"low":0.008,"week52Low":0.007,"pbRate":"-1.87","psRate":"11.18","week52High":0.055,"institutionHeld":0,"latestPrice":0.008,"eps":-0.010968,"divideRate":0,"volume":2979293,"delay":0,"ttmEps":-0.010968,"open":0.008,"prevYearClose":0.025,"prevWeekClose":0.008,"prevMonthClose":0.008,"prevQuarterClose":0.011,"fiveDayClose":0.008,"twentyDayClose":0.011,"sixtyDayClose":0.015,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-11-16","symbol":"IBX.AU","defaultRemindTime":1700089200000,"type":"split","dateTimestamp":1700053200000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185697396","title":"Imagion Biosystems獲FDA二期臨床試驗許可後成功融資375萬澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185697396","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185697396?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 23:52","pubTimestamp":1782402734,"startTime":"0","endTime":"0","summary":"在获得美国食品药品监督管理局（FDA）对其二期临床试验的许可后，Imagion Biosystems成功完成了375万澳元的资本募集。这一进展为公司的临床研究计划注入了关键资金，标志着其在医疗技术开发领域迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}